Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
Titel:
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
Auteur:
Kaufman, Bella Trudeau, Maureen Awada, Ahmad Blackwell, Kimberly Bachelot, Thomas Salazar, Vanessa DeSilvio, Michelle Westlund, Ronald Zaks, Tal Spector, Neil Johnston, Stephen